HSP90AB1 and leukemia: Although the exact mechanism by which HSP90 inhibitors interfere with leukaemia cell survival is not fully understood, we have also demonstrated that 17-AAG was able to induce apoptosis in primary AML cells, in correlation with HSP90 and activated AKT levels [16].